Skip to content

Cost analysis of two anaesthetic machines - Aisys (GE) and ZEUS IE (Dräger)

Cost analysis of two anaesthetic machines - Aisys (GE) and ZEUS IE (Dräger) - AZIETrial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004754
Enrollment
100
Registered
2013-02-22
Start date
2013-03-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anaesthesia during interventions in visceral surgery.

Interventions

Group 1: Detect the usage of oxygen, medical air and Sevoflurane in cloosed loop mode at the aneasthetic machine Aisys (GE). Evaluate the costs of operation. Group 2: Detect the usage of oxygen, medic

Sponsors

Universitätsmedizin Göttingen Zentrum Anästhesioloige, Rettungs- u. Intensivmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 99 Years

Inclusion criteria

Inclusion criteria: Surgical intervention in the Department of general and visceral surgery.

Exclusion criteria

Exclusion criteria: Age of of the range from 14-99, Case history of heavy postoperative nausea and vomiting. Patients with the risk score higher than ASA 4.

Design outcomes

Primary

MeasureTime frame
The primary end point and the scientific question ist to find out the difference in the usage of volatile anaesthetics, oxygen and medical air of the anaesthetic machines. We will also take a look to the costs generated in clinical usage by attendance and consumable material. We will calculate the usage of gas with the help of a manometer and the usage of sevoflurane with a precision scale. The cost of operation will be determinated through the material cost of consumable material and the cost depending on maintanance. The acquisition costs of the anaesthetic machine will be considered.

Countries

Germany

Contacts

Public ContactArne Blecken

Universitätsmedizin Göttingen Zentrum Anästhesioloige, Rettungs- u. Intensivmedizin

arne.blecken@med.uni-goettingen.de01713873503

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026